BackMeribank Biotech , Ltd Overview

Meribank Biotech , Ltd Other Liabilities

Meribank Biotech , Ltd's other liabilities is $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Meribank Biotech , Ltd Other Liabilities History

Loading

Meribank Biotech , Ltd vs. peers: Other Liabilities Comparison

Loading

Meribank Biotech , Ltd Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Meribank Biotech , Ltd (4724.TWO) FAQ

Meribank Biotech , Ltd's other liabilities stands at $0 as of June 2026. In the prior-year period, the figure was $0. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Meribank Biotech , Ltd reported $0 in other liabilities versus $0 a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

In the prior-year period, the figure was $0. Sustained growth in other liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Meribank Biotech , Ltd's other liabilities evolved across reporting periods, while the comparison chart places 4724.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, other liabilities is commonly used to spot outliers. Meribank Biotech , Ltd's reading of $0 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.